It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

These growth stocks come from two very different industries. Eli Lilly is riding the GLP-1 drug wave, but there is much more ...

The AP-NORC poll shows about half of Americans “strongly” or “somewhat” favor having the federal programs Medicare and Medicaid cover weight-loss drugs for people who have obesity, while about 2 in 10 ...

Communications services companies fell after weak earnings from one cable giant. Comcast shares slid as investors appeared to zero in on a bigger-than-expected drop in broadband customers, rather than ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view ...

If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...

Actually, the best way to lose weight, doctors agree, is through healthy diet and physical activity. People always crave the fastest and easiest, but fast and easy do not always equal best. Physical ...

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.